CEACAM5 and colorectal carcinoma: Serum CEA alone may not be a good screening test and it may be a little bit more expensive than FIT though it has been widely used in the surveillance of patients following primary surgical resection of CRC [24, 25] but it may be possible to be used as one of primary screening tests combining with other biomarkers such as FIT in mass screenings.